Atlas Trials

Assessing Exercise Capacity After PulseHaler™ Treatment in GOLD II-IV COPD Patients

Clinical trial NCT04236076 · UNKNOWN

Trial details

NCT number
NCT04236076
Sponsor
Respinova LTD
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COPD
Start date
2020-05-01
Primary completion
2021-05-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.